Tariffs are not the main barrier to Indian research

This article reports that U.S. tariffs are not the primary obstacle holding back Indian research and development. The author argues that industries exposed to American trade measures spend very little on R and D, while Indian innovation is largely concentrated in pharmaceuticals and automobiles. Furthermore, the private sector's overall spending remains low compared to global standards. The piece suggests that to truly foster innovation, government support and incentives should be directly tied to research efforts rather than simply offering broad relief to exposed sectors.

This article reports that Canada is preparing to impose retaliatory tariffs ranging from 15% to 50% on hundreds of U.S. products as Prime Minister Mark Carney attempts to strengthen Ottawa's negotiating position. The trade dispute escalated after preliminary talks collapsed due to disagreements over terms and accusations of bad faith from both governments. While the Canadian public largely supports the countermeasures, economists warn that the escalating trade war will likely reduce economic output and increase costs. Both sides have expressed a desire for a durable agreement eventually, though no new meetings have been scheduled.